Skip to the page

Data / Drug companies / Advanced Dispersed Particles SL.

Advanced Dispersed Particles SL.: 17 products in the FDA NDC directory, labeler code 70161

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Advanced Dispersed Particles SL. (labeler code 70161) lists 17 products in the FDA National Drug Code Directory. By type: 17 drugs for further processing. Its main marketing category is drugs for further processing. The newest product started marketing on March 22, 2024.

The request: Watch Advanced Dispersed Particles SL. (FDA labeler code 70161): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
70161
Products in commercial distribution
17
Packages
51
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Started marketing in the last 12 months
0
Earliest marketing start
January 1, 2019
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Drugs for further processing17100%

Products by type

TypeProductsShare
Drugs for further processing17100%

Dosage forms

Dosage formProductsShare
Powder17100%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Zinc oxide70161-027PowderDrugs for further processingMarch 22, 2024
Zinc oxide70161-026PowderDrugs for further processingMarch 22, 2024
Zinc oxide70161-025PowderDrugs for further processingMarch 22, 2024
Zinc oxide70161-024PowderDrugs for further processingMarch 22, 2024
Zinc oxide70161-023PowderDrugs for further processingMarch 22, 2024
Zinc oxide70161-022PowderDrugs for further processingMarch 22, 2024
Titanium dioxide70161-021PowderDrugs for further processingSeptember 5, 2019
Titanium dioxide70161-020PowderDrugs for further processingSeptember 5, 2019
Titanium dioxide70161-019PowderDrugs for further processingJanuary 1, 2019
Titanium dioxide70161-018PowderDrugs for further processingJanuary 1, 2019
Titanium dioxide70161-017PowderDrugs for further processingJanuary 1, 2019
Titanium dioxide70161-016PowderDrugs for further processingJanuary 1, 2019
Titanium dioxide70161-015PowderDrugs for further processingJanuary 1, 2019
Titanium dioxide70161-014PowderDrugs for further processingJanuary 1, 2019
Titanium dioxide70161-013PowderDrugs for further processingJanuary 1, 2019
Titanium dioxide70161-012PowderDrugs for further processingJanuary 1, 2019
Zinc oxide, titanium dioxide70161-011PowderDrugs for further processingJanuary 1, 2019

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.